市場調查報告書
商品編碼
1452587
歐洲家禽診斷市場預測至 2030 年 - 區域分析 - 按測試類型和疾病(禽沙門氏菌病、禽流感、新城疫、禽支原體病、傳染性支氣管炎等)Europe Poultry Diagnostic Market Forecast to 2030 - Regional Analysis - By Test Type and Disease (Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Mycoplasmosis, Infectious Bronchitis, and Others) |
歐洲家禽診斷市場預計將從2022年的5,450萬美元成長到2030年的1.2,136億美元。預計2022年至2030年CAGR為10.5%。
政府支持和措施推動歐洲家禽診斷市場
在歐洲,各國政府優先考慮嚴格的監管框架,以維護家禽業的完整性和安全性。例如,歐盟 (EU) 實施由歐盟委員會健康與食品安全總司 (DG SANTE) 監督的綜合法規。這些法規包括旨在保障家禽健康的嚴格的生物安全措施、疾病預防方案和衛生標準。
荷蘭和法國等歐盟國家擁有自己的國家監管機構,其工作符合歐盟標準。此外,荷蘭食品和消費品安全局 (NVWA) 也在全國家禽養殖場監督和執行嚴格的生物安全措施和疾病管制協議。同樣,法國農業和食品部確保實施強力的法規,重點關注疾病預防、疫苗接種計劃和嚴格監測家禽健康。
此外,歐洲食品安全管理局 (EFSA) 在獲取家禽健康相關潛在風險並提供科學建議方面發揮至關重要的作用,有助於在整個歐盟制定和實施有效的監管措施。
歐洲各地這些嚴格的監管框架強調了確保家禽健康、安全和品質高標準的承諾。它們強調了該地區致力於維護國際標準、確保消費者信心並保持歐洲家禽業的競爭力。
歐洲家禽診斷市場概況
歐洲家禽診斷市場分為德國、英國、法國、義大利、西班牙和歐洲其他地區。不斷增加的家禽疾病和政府為克服這種情況而採取的舉措是推動歐洲市場成長的主要因素。歐盟實施了針對人畜共通傳染病的擴展控制計劃,其中沙門氏菌被列為優先事項。這些計劃包括提供科學建議和限制受感染雞群產品的貿易。德國歐洲家禽診斷市場的推動因素包括新測試創新的研發活動增加、家禽中禽流感等傳染病流行率的上升以及新測試的採用。 2020年11月至2021年5月期間,德國遭遇了有史以來最大規模的高致病性禽流感疫情,家禽和圈養鳥類爆發了245起疫情,野生鳥類確診病例超過1000例。 2021年3月,一家待售蛋雞飼養場確認爆發H5N8型高致病性禽流感疫情。 2020 年,在下薩克森州的一個家禽養殖場檢測到了德國 HPAI 的 H5N8 病毒變種。因此,預計上述因素將在預測期內推動德國的歐洲家禽診斷市場。
歐洲家禽診斷市場收入及 2030 年預測(百萬美元)
歐洲家禽診斷市場細分
歐洲家禽診斷市場分為測試類型、疾病和國家。
根據測試類型,歐洲家禽診斷市場分為酵素連結免疫吸附測定(ELISA)測試、聚合酶鏈反應(PCR)測試、血凝抑制(HI)測試等。 2022 年,酶聯免疫吸附測定 (ELISA) 測試領域佔據歐洲家禽診斷市場的最大佔有率。
疾病方面,歐洲家禽診斷市場分為禽流感、傳染性支氣管炎、禽沙門氏菌病、新城疫、禽支原體病等。 2022 年,禽流感細分市場在歐洲家禽診斷市場中佔據最大佔有率。
按國家/地區分類,歐洲家禽診斷市場分為德國、西班牙、法國、英國、義大利和歐洲其他地區。德國在 2022 年主導歐洲家禽診斷市場。
Thermo Fisher Scientific Inc、Idex Laboratories Inc、Qiagen NV、Eurofins Scientific SE、IDVET、Boehringer Ingelheim International GmbH、Zoetis Inc、BioCheck BV 和 BioInGenTech Biotechnologies 是歐洲家禽診斷市場上的一些領先公司。
The Europe poultry diagnostic market is expected to grow from US$ 54.50 million in 2022 to US$ 121.36 million by 2030. It is estimated to grow at a CAGR of 10.5% from 2022 to 2030.
Government Support and Initiatives Fuel Europe Poultry Diagnostic Market
In Europe, governments prioritize stringent regulatory frameworks to uphold the integrity and safety of the poultry industry. For instance, the European Union (EU) implements comprehensive regulations overseen by the European Commission's Directorate-General for Health and Food Safety (DG SANTE). These regulations encompass strict biosecurity measures, disease prevention protocols, and hygiene standards aimed at safeguarding poultry health.
Countries within the EU, such as the Netherlands and France, have their own national regulatory bodies that work in alignment with EU standards. Additionally, the Netherlands Food and Consumer Product Safety Authority (NVWA) monitors and enforces stringent biosecurity measures and disease control protocols in poultry farms across the country. Similarly, France's Ministry of Agriculture and Food ensures the implementation of robust regulations, focusing on disease prevention, vaccination programs, and strict monitoring of poultry health.
Additionally, the European Food Safety and Authority (EFSA) plays a crucial role in accessing and providing scientific advice on potential risks related to poultry health, contributing to the development and implementation of effective regulatory measures across the EU.
These stringent regulatory frameworks across Europe emphasize the commitment to ensuring high standards of poultry health, safety, and quality. They underscore the region's dedication to upholding international standards, ensuring consumer confidence, and maintaining the competitiveness of the European poultry industry.
Europe Poultry Diagnostic Market Overview
The Europe poultry diagnostic market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. The rising poultry diseases and government initiatives to overcome the situation are the major factors driving the market growth in Europe. The EU implemented extended control programs for zoonotic diseases, with Salmonella set as a priority. These programs include the provision of scientific advice and limitations on the trade of products from infected flocks. The Europe poultry diagnostic market in Germany is driven by increased R&D activities for the innovation of newer tests, a rise in the prevalence of infectious diseases such as bird flu in poultry, and the adoption of newer tests. Between November 2020 and May 2021, Germany faced the largest epidemic recorded of HPAI, with 245 outbreaks in poultry and captive birds and more than 1,000 diagnosed cases in wild birds. In March 2021, an HPAI outbreak of subtype H5N8 was confirmed in a holding rearing laying hens for sale. The H5N8 virus variant of HPAI in Germany was detected at a poultry farm in Lower Saxony in 2020. Thus, the abovementioned factors are expected to drive the Europe poultry diagnostic market in Germany during the forecast period.
Europe Poultry Diagnostic Market Revenue and Forecast to 2030 (US$ Million)
Europe Poultry Diagnostic Market Segmentation
The Europe poultry diagnostic market is segmented into test type, disease, and country.
Based on test type, the Europe poultry diagnostic market is segmented into enzyme-linked immunosorbent assay (ELISA) tests, polymerase chain reaction (PCR) tests, hemagglutination-inhibition (HI), and others. The enzyme-linked immunosorbent assay (ELISA) tests segment held the largest share of the Europe poultry diagnostic market in 2022.
In terms of disease, the Europe poultry diagnostic market is segmented into Avian Influenza, Infectious Bronchitis, Avian Salmonellosis, Newcastle Disease, Avian Mycoplasmosis, and Others. The Avian Influenza segment held the largest share of the Europe poultry diagnostic market in 2022.
By country, the Europe poultry diagnostic market is segmented into the Germany, Spain, France, UK, Italy, and the Rest of Europe. The Germany dominated the Europe poultry diagnostic market in 2022.
Thermo Fisher Scientific Inc, Idexx Laboratories Inc, Qiagen NV, Eurofins Scientific SE, IDVET, Boehringer Ingelheim International GmbH, Zoetis Inc, BioCheck BV, and BioInGenTech Biotechnologies are some of the leading companies operating in the Europe poultry diagnostic market.